| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.79B | 73.18B | 61.91B | 43.19B | 31.89B | 24.01B |
| Gross Profit | 51.71B | 48.64B | 40.74B | 36.93B | 24.49B | 16.81B |
| EBITDA | 3.02B | 3.39B | 6.10B | 39.41B | -2.38B | 2.81B |
| Net Income | 1.18B | 1.25B | 2.33B | 869.31M | -15.44B | -5.08B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 112.29B | 95.77B | 80.94B | 93.53B | 87.26B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 10.87B | 10.72B | 7.98B | 25.26B | 16.20B |
| Total Debt | 0.00 | 2.33B | 4.43B | 8.41B | 49.37B | 49.40B |
| Total Liabilities | -34.37B | 77.92B | 64.08B | 54.16B | 98.85B | 84.28B |
| Stockholders Equity | 34.37B | 25.16B | 23.43B | 20.58B | -9.82B | -470.86M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 15.47B | 14.78B | 14.66B | 15.56B | 13.54B |
| Operating Cash Flow | 0.00 | 15.72B | 15.00B | 15.06B | 15.96B | 13.73B |
| Investing Cash Flow | 0.00 | -11.85B | -13.48B | -9.39B | -6.89B | -11.81B |
| Financing Cash Flow | 0.00 | -2.85B | -1.56B | -20.79B | 5.59B | -3.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ₹80.65B | 6.64 | ― | 2.16% | 7.08% | 7.69% | |
77 Outperform | ₹104.68B | 7.71 | ― | 1.00% | 8.09% | 2.68% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | ₹77.43B | 73.67 | ― | ― | 8.35% | -50.99% | |
60 Neutral | ₹104.75B | 25.09 | ― | 2.78% | 6.15% | -64.12% | |
56 Neutral | ₹67.11B | -73.60 | ― | 1.72% | 10.02% | -120.18% |
Religare Enterprises Limited announced a special window for shareholders to re-lodge transfer requests of physical shares that were previously rejected or unattended due to document deficiencies. This initiative, following a SEBI circular, aims to address past administrative issues, potentially improving shareholder satisfaction and operational efficiency.
Religare Enterprises Limited has released an investor presentation detailing its operational and financial performance for the quarter and half year ending September 30, 2025. The presentation, which is available on the company’s website, is part of the preparations for an upcoming earnings call. This announcement is significant as it provides stakeholders with insights into the company’s recent performance and strategic direction.
Religare Enterprises Limited announced its compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending September 30, 2025. This compliance, confirmed by KFin Technologies Limited, ensures that the company’s securities dematerialization processes are in line with regulatory standards, potentially enhancing stakeholder confidence in its operational integrity.
Religare Enterprises Limited has announced that its subsidiary, Care Health Insurance Ltd. (CHIL), has received a confirmation from the Joint Commissioner, Common Adjudicating Authority, CGST Commissionerate, Faridabad, regarding a GST demand of ₹35.92 crore, along with a penalty and applicable interest for the period from July 2017 to March 2022. This confirmation follows a directive from the Bombay High Court to reassess a previous order related to industry-wide issues concerning non-payment of GST on co-insurance and re-insurance transactions. The company plans to appeal or consider other actions against this order.